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Abstract N-Alkyltheobromine (1–9) derivatives were
obtained by reacting theobromine with appropriate alkyl
halide under microwave irradiation at 100–150 W and by
conventional synthesis. Formation of by-products of oxy-
gen atom alkylation and 1-N-alkyltheobromine ring open-
ing were considered. The presented compounds 1–5 have
been studied as ion carriers in ion-selective membrane
electrodes. Selectivity of these membranes was studied
towards various anions in addition to transition and heavy
metal cations.
Keywords Theobromine  Alkylation  Impurities 
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Introduction
Methylxanthines are pharmacologically and biologically
active compounds, which are commonly used as mild
stimulants, bronchodilators and adenosine receptor antag-
onist [1]. One of the N-alkyltheobromines derivatives,
which is clinically useful for the treatment of peripheral
vascular disease, cerebrovascular disease and a number of
other illnesses involving a defective regional microcircu-
lation is pentoxifylline [2]. This active hemorheological
agent inhibits the synthesis of tumor necrosis factor-a [3]
and this effect has been attributed to inhibition of cyclic
AMP phosphodiesterase [4]. The most general method of
synthesis 1-substituted theobromine is based on cyclization
reaction of imidazole or 6-aminouracil derivatives [5].
Alternative approaches to the previous method is two-step
cyclocondensation of 4-amino-5-alkoxycarbonyl-imida-
zoles with isocyanates or treatment theobromine with an
excess of alkyl halide, sometimes under pressure, at tem-
perature of 80–100 C [6–11]. Preliminary studies have
shown that similar derivatives could be obtained by using
microwave irradiation [12, 13]. According to present
knowledge this method is high yield and less time con-
suming. It is often used for multi-step synthesis, drug
production and whenever easy purification is highly rec-
ommended. The aim of this work was preparation of
N-alkyltheobromines and presentation of their properties in
ion-selective membrane electrodes (Fig. 1). There are only
few papers dealing with this subject. The behavior of these
compounds as ionophores in ion-selective membrane
electrodes has received no attention yet in the literature.
Results and discussion
Synthesis
Theobromine molecule has two potential sites for N-alkyl-
ation showing different acidities of the N–H bond. Under
alkaline conditions alkylation of theobromine proceeds in
N1 position, because the nucleophilicity of N9 is much
lower than the former. The electrophilic attack on the N9
position proceeds under special condition. Theobromine,
like other purines exist in two tautomeric forms (Fig. 2).
Ketone form dominates under the equilibrium. At the
presence of sodium or sodium/potassium hydroxide the
equilibrium is shifted and O-alkylation is possible. Under
basic conditions, another reaction is opening of uracil ring
(Scheme 1).
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In the light of the above properties we decided to test
influence of factors such as, solvent, temperature, time,
microwave irradiation and presence of phase transfer cat-
alyst on selectivity of 1-N substitution. Reaction rate and
side product formation was monitored by thin layer chro-
matography (TLC).
Synthesis of pentoxifylline in reaction of theobromine
with 6-chlorohexanone was chosen as a research model. In
all reaction 2.5 mmol of theobromine and 2.5 mmol of
6-chlorohexanone were used. Solvents volume was 5 mL,
quantity of base and phase transfer catalyst was 5 and
0.25 mmol, respectively. The crude product was obtained
by solvent evaporation under reduced pressure, extraction
with petroleum ether (unreacted electrophilic reagent
removal) and methylene chloride, filtration of inorganic
salts, theobromine and insoluble impurities, and solvent
evaporation from the filtrate.
First five common industrial solvents possessing dif-
ferent properties were examined (Fig. 3). The mixture of
theobromine and 6-chlorohexanone and appropriate solvent
was stirred for 8 h under reflux in case of alcohols and at
100 C if DMF and DMSO were used.
The best yield was achieved using DMF as solvent.
Reactions in methanol, ethanol and propan-2-ol gave very
low yield. We assumed that the reason was relatively low
boiling point of alcohols and highly insufficient solubility
of theobromine. The reaction in DMSO required longer
time and gave a lot of by-products. Furthermore, solvent
free conditions were applied. Reaction was carried out in
an excess of alkyl halide at 100 C for 5 and 12 h. After 5 h

















Scheme 1 Opening of uracil ring of theobromine
Fig. 3 Solvent influence on yield of theobromine reaction product
with 6-chlorohexanone. 1 Methanol (8%), 2 ethanol (15%), 3 propan-
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Fig. 2 Tautomeric forms of theobromine
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the product was highly contaminated. It implies that pro-
longed reaction/heating time determinates formation of by-
products. Due to promising results, in next experiments
only DMF was used as solvent.
Limited solubility of theobromine suggested usage of
phase transfer catalyst. Five different catalysts were tested
(NMe4Br, NEt4Br, NBut4Br, NBzEt4Br, and NBut4I). The
mixture of theobromine, 6-chlorohexanone and phase
transfer catalyst in DMF was stirred at 100 C for 8 h. The
highest yield of crude product was obtained when tetra-
butylammonium iodide was applied (see Fig. 4).
Usually, alkylation of nitrogen atom requires presence
of appropriate base, which allows formation of ionic
intermediates, which is involved in catalytic phase transfer
reaction in solid–liquid system. In experiments anhydrous
potassium carbonate, sodium carbonate, lithium carbonate
and potassium bicarbonate were tested. The highest yield
was obtained in case of potassium bicarbonate (Fig. 5). Use
of stronger bases such as potassium hydroxide increases
formation of by-products.
To investigate influence of temperature, the reaction was
carried out in a 60–140 C range of temperature (Fig. 6).
The yield of desired product was insufficient at temperature
of 60–90 C. At 120–140 C the reaction rate was satis-
factory, but the product was strongly contaminated. Con-
sidering reaction chart (Fig. 6) the optimal temperature
100–110 C was assumed to be favorable.
We noticed that formation of impurities is time depen-
dent. The optimal time was 8 h. Increasing the time of
reaction caused sufficient increase of by-products concen-
tration, especially detectable under UV (k = 365 nm).
Moreover, the reaction mixture is darkening with time and
isolation of the desired product becomes more complicated
(Fig. 7).
We found that xanthine’s ring degradation is fast in
presence of strong base (KOH). Under mild conditions
(K2CO3) higher temperature and longer time of reaction is
required. Figure 8 exemplifies the 1H NMR of pentoxif-
ylline and its degradation product.
Alkylation of oxygen atom was observed when strong
base (KOH) was used. Therefore only isomer with alkyl-
ated oxygen atom in two position was isolated by column
chromatography. In case of potassium carbonate the
Fig. 4 Phase transfer catalyst influence on yield of theobromine
reaction product with 6-chlorohexanone. 1 NEt4Br (73%), 2 But4I
(77%), 3 NBzEt4Br (75%), 4 NEt4Br (73%), 5 NMe4Br (73%)
Fig. 5 Base influence on yield of theobromine reaction product with
6-chlorohexanone. 1 K2CO3 (73%), 2 Na2CO3 (77%), 3 Li2CO3 (0%),
4 KHCO3 (90%)
Fig. 6 Influence of temperature on the yield of pentoxifylline
Fig. 7 Time influence on the yield of pentoxifylline
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mixture of two isomers was obtained, but the yield was
very poor. Figure 9 shows alkylation products of enol form
of theobromine with 6-chlorohexanone. The main com-
pound was 3,7-dihydro-2-(5-oxohexyloxy)-3,7-dimethyl-
6H-purine-6-one. The isomer ratio is roughly 2:1.
A mixture of: theobromine, appropriate alkylating
reagent, K2CO3, [CH3(CH2)3]4NI in dry DMF was stirred
for 8 h at temperature 100 C in next experiments. Then
solvent was evaporated under reduced pressure. The resi-
due was extracted with petroleum ether to remove
remaining hydrocarbon halide, then with methylene chlo-
ride to separate the product from inorganic salts, theobro-
mine and insoluble impurities. The crude product and its
discussed impurities obtained after solvent evaporation
were separated by column chromatography (Table 1).
Syntheses on microwave irradiation are very popular,
recently. Microwave-assisted organic synthesis has several
advantages over conventional reactions in that the micro-
wave allows for an increase in reaction rate, rapid reaction
optimization, and rapid analogue synthesis. It also uses
both less energy and solvent, and it enables difficult
compound synthesis. Therefore, in next experiments
microwave reactor was used. The applied device reactor
has maximum delivered power of 1,000 W. It has built in
magnetic stirrer, and power and temperature control units.
The mixture described above was irradiated for 20, 30 or
Fig. 8 1H NMR (200 MHz, CDCl3) of pentoxifylline and its degradation product
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60 min at 10–15% of microwave power (Scheme 2). The
yield of the products ranged from 83 to 99%. Moreover, all
obtained compounds were extremely pure. Discussed
impurities have not been noticed. Results of our experi-
ments are presented in Table 2.
Membrane electrode
In general, all membranes for ion response contained 1
wt% ionophore (1–5), 30–33 wt% polyvinyl chloride
(PVC), 66–67 wt% 2-nitrophenyl octyl ether (o-NPOE) and
0.1 wt% of potassium tetrakis(4-chlorophenyl) borate
(KTpClPB). The membrane components, total 100 mg,
were dissolved in 1 mL of freshly distilled THF. The
solution (170.5 lL) was applied onto graphite screen-
printed electrodes and the electrodes were left to dry over
24 h. Next after evaporation of the solvent overnight the
electrodes were conditioned in deionized water for 10 h.
A double-junction Ag/AgCl, KCl 1 M reference electrode
(Monokrystaly RAE 112) was used with 1 M NH4NO3
solution in the bridge cell. The measurements were carried
out at 20 C, using the following cell: Ag/AgCl/internal
electrolyte/ion-selective membrane/sample/1 M NH4NO3/
1 M KCl/AgCl/Ag and 16-channel LAWSON LAB
potentiometer.
Potentiometric selectivity coefficients were determined
by the separate solution method (SSM), according to a
procedure established by Bakker [14]. Selectivity coeffi-
cients were calculated according to equation below, by
using the EMF values for the highest measured ion activ-





















Scheme 2 Alkylation reaction of theobromine with hydrocarbon
halides
Fig. 9 1H NMR (500 MHz, CDCl3) of pentoxifylline and its alkylated oxygen products
Table 1 The yields of separated products by column chromatography






1 90 2 5
2 70 2 10
3 90 2 6
4 90 3 5
5 89 3 5
6 87 3 8
7 80 3 9
8 89 2 8
9 87 3 8










1 80–90 150 0.5 98
2 90–100 100 0.5 83
3 90–100 150 0.33 92
4 90–100 100 1 98
5 90–100 150 0.33 99
6 90–100 100 1 87
7 100–110 150 0.5 83
8 90–100 100 0.5 92.5
9 90–100 100 0.5 97
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ion. In order to achieve unbiased values of selectivity
coefficients the calibration of the electrodes was performed
for various cations, starting preferably from the most dis-
criminating. Activity coefficients for ions were calculated
in agreement with Debye–Huckel approximation.
log KpotI;J ¼







As yet no data have been reported on behavior of com-
pounds 1–5 in ion-selective membrane electrodes. We
expected that N-alkyltheobromines should be selective to
some transition and heavy metal cations. The solutions of
nitrate of Zn(II), Cu(II), Ni(II), Co(II), Cd(II), Pb(II),
Ag(II) and Hg(I) cations were examined. In a preliminary
experiments the ion-selective membrane electrodes doped
with 1–5 were selective for the copper(II) cation. The
electrode slopes for Cu(II) have been found close to the
Nerstian value: 28.7 mV/dec (compound 1), 29.3 mV/dec
(compound 2), 27.9 mV/dec (compound 3), 28.3 mV/dec
(compound 4) and 27.3 mV/dec for compound 5. The
selectivity coefficients are presented in Table 3 and
Fig. 10. Column 6 represents the selectivity for electrodes
with PVC/o-NPOE based membranes without ionophore
(blank electrode) and containing the cation exchanger. The
results show that the Pb(II), Co(II) and Zn(II) belongs to
ions most discriminated by the studied N-alkyltheobro-
mines. Membrane doped with compound 5 shows better
affinity towards Pb(II), Cd(II) and Zn(II) than electrode
with compound 4. That might be caused by the further
aromatic ring which contributes the highest values of
selectivity coefficients for Ag(I) and Hg(I): log
KCu,J = 4.881 and log KCu,J = 4.829, respectively. More-
over, it can be seen from Fig. 10 that the incorporation of
longer carbon chain (18 carbon) induce selectivities slight
different from the selectivity based on compound 2 with
eight carbon chain. Membranes doped with the compound
2 show higher affinity towards Zn(II) (log KCu,J = 3.063)
and Ni(II) (log KCu,J = 2.676), whereas membranes with
compound 3 are more selective towards Cd(II) (log
KCu,J = 2.50).
In the preliminary experiments we investigate the
potentiometric response towards various anions, such as:
bromide, iodide, fluoride and acetate. Before measurements
electrodes were conditioned in Cu(NO3)2 0.01 M solution
for 10 h. The selectivity pattern of an electrode based on
the N-alkyltheobromines is presented in Fig. 11. Electrodes
based on 1, 3, 4 responded with nearly theoretical slopes
(-52 to -60 mV/dec) for iodide ion.
Conclusions
In conclusion, alkylation of theobromine with appropriate
alkyl halide under microwave irradiation have been per-
formed. The microwave-assisted process comparing to
conventional heating, gives the higher yields in much
shorter time without by-products such as oxygen atom
alkylation and 1-N-alkyltheobromine ring opening. This
method confirms that microwave irradiation allow products
synthesis with potential medical application in easy way
Table 3 Potentiometric selectivity coefficients given as log KCu,J of
membrane electrodes with ionophores (1–5) and for comparison blank
electrode
Ion 1 2 3 4 5 Blank
Zn2? 1.749 3.063 1.73 1.193 -0.659 1.946
Ni2? 0.376 2.676 1.388 0.798 1.292 0.461
Co2? -0.362 2.554 2.62 -0.281 2.693 1.898
Cd2? 0.098 0.085 2.50 -0.427 2.937 -1.99
Pb2? -0.48 0.035 0.172 -0.247 0.930 -0.29
Ag? 4.916 3.953 3.90 4.881 3.372 4.34
Hg? 4.598 3.113 3.92 4.829 3.2 4.279
H? 1.255 0.838 0.76 1.31 1.303 1.017
Fig. 10 Selectivity coefficient,
determined as log KCu,J by the
SSM
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with good yields. The properties of N-alkyltheobromine
derivatives have been characterized potentiometrically in
polymeric ion-selective membranes.
Experimental section
All materials and solvents used for syntheses were of
analytical reagent grade. TLC were performed on alumin-
ium plates covered with Silica gel 60 F254 (Merck).
1H
NMR spectra, all in CDCl3, were taken on Varian instru-
ments at 200 and 500 MHz. IR and mass spectra were
recorded on AMD-604 and Genesis II (Mattson) apparatus,
respectively. Mass spectra were determined with AMD 604
instrument. Elemental analyses were obtained on EAGER
200 apparatus. The melting points were uncorrected. The
microwave-assisted reactions were performed in micro-
wave reactor, Plazmatronika (RM 800). The microwave
has a power supply—230 V ± 10%/50 Hz with a maxi-
mum delivered power of 1,000 W. High molecular weight
PVC, KTpClPB, NPOE and tetrahydrofuran were pur-
chased from Fluka. The screen-printed graphite electrodes
used were obtained from Institute of Electronic Materials
Technology, Warsaw (plates of 18–15 mm with six
electrodes, openings area ca. 1 mm2). All aqueous
solution were prepared from salts of p.a. purity using




A mixture of theobromine (0.45 g, 2.5 mmol), alkyl halide
(2.5 mmol), potassium carbonate (0.69 g, 5 mmol), tetra-
butylammonium iodide (10 mmol%) and dimethylform-
amide (5 mL) was stirred for 8 h in 100 C. Then the DMF
excess was removed on a rotary evaporator. The residue
was extracted with petroleum ether (20 mL) to remove
remained electrophilic reagent and next the product was
extracted with CH2Cl2 (20 mL). The undissolved material
was filtered off. The filtrate was concentrated under
reduced pressure and purified by column chromatography
on silica gel.
Microwave-assisted synthesis—general procedure
A mixture of theobromine (0.45 g, 2.5 mmol), alkyl halide
(2.5 mmol), potassium carbonate (0.69 g, 5 mmol), tetra-
butylammonium iodide (10 mmol%) and dimethylform-
amide (5 mL) was carried out in a Microwave reactor. The
reaction mixtures were irradiated under temperatures and
microwave power reported in Table 2. The reaction pro-
gress was monitored by TLC. After reaction the solvent
was removed on a rotary evaporator. The solid residue was
extracted with petroleum ether (20 mL) to remove
remained electrophilic reagent and then the product was
extracted with CH2Cl2 (20 mL). The solvent was removed
under reduced pressure and the crude product was purified
by recrystallization using a suitable solvent.
3,7-Dihydro-3,7-dimethyl-1-(3-chloropropene)-1H-purine-
2,6-dione (1) White solid, mp 135–137 C, solvent
for crystallization: ethyl acetate/petroleum ether (1/1).
1H NMR (200 MHz, CDCl3): d = 7.56 (s, 1H, CH), 6.4
(d, J = 14.3 Hz, 1H, =CH–Cl), 6.11–5.98 (m, 1H, –CH=),
4.0 (d, J = 7.12 Hz, 2H, CH2–N), 3.98 (s, 3H, CH3), 3.57
Fig. 11 Selectivity pattern of an electrode based on the compounds:
a 1, b 3, c 4. The electrode was exposed to sodium: bromide, iodide,
fluoride and acetate
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(s, 3H, CH3) ppm. HRMS (EI) calcd. for C10H11ClN4O2:
m/z = 254.05705, found: 254.05689. IR (film): 2959,
2926, 2855, 1705, 1661, 1605, 1550, 1461, 1358, 1324,
1286, 1234, 1121, 763, 750, 616 cm-1. Anal. calcd. for
C10H11ClN4O2: C 47.27, H 4.36, N 22.05, Cl 13.95; found:
C 47.29, H 4.41, N 22.13, Cl 13.89.
1-Methyl-4-(methylamino)-1H-imidazole-5-N-(3-chloro-
propene)-carboxamide Yellow oil. 1H NMR (200 MHz,
CDCl3): d = 7.45 (s, 1H, CH), 6.90 (N–H, 2H), 6.7 (d,
J = 14.1 Hz, 1H, =CH–Cl), 6.65–6.50 (m, 1H, –CH=),
4.04 (d, J = 7.10 Hz, 2H, CH2–N), 3.84 (s, 3H, CH3), 3.43
(s, 3H, CH3) ppm. HRMS (EI) calcd. for C9H13ClN4O:
m/z = 228.67872, found: 228.67925. IR (film): 3129, 3010,
2959, 2926, 2855, 1705, 1661, 1605, 1461, 1358, 1324, 1286,
1234, 1121, 1025, 973, 763, 750, 616, 550 cm-1. Anal.
calcd. for C9H13ClN4O: C 47.27, H 5.73, N 24.50, Cl 15.50;
found: C 47.35, H 5.68, N 24.49, Cl 15.63.
3,7-Dihydro-2-chloropropenoxy-3,7-dimethyl-6H-purine-
6-one Colorless oil. 1H NMR (200 MHz, CDCl3):
d = 7.56 (s, 1H, CH), 6.27–6.22 (m, 1H, =CH–Cl),
6.15–6.10 (m, 1H, –CH=), 5.04 (d, J = 6.8 Hz, CH2O),
4.02 (s, 3H, CH3), 3.79 (s, 3H, CH3) ppm. HRMS (EI)
calcd. for C10H11ClN4O2: m/z = 254.05705, found:
254.05739. IR (film): 3010, 2959, 2926, 2875, 2855, 1705,
1605, 1461, 1358, 1324, 1286, 1234, 1270, 1121, 1075,
763, 750, 616 cm-1. Anal. calcd. for C10H11ClN4O2: C
47.27, H 4.36, N 22.05, Cl 13.95; found: C 47.32, H 4.46,
N 22.19, Cl 13.98.
3,7-Dihydro-3,7-dimethyl-1-(octyl)-1H-purine-2,6-dione
(2) White solid, mp 89–93 C, solvent for crystallization:
ethanol. 1H NMR (500 MHz, CDCl3): d = 7.52 (s, 1H,
CH), 4.03–3.99 (m, 5H, N–CH2, CH3), 3.59 (s, 3H, CH3),
1.71–1.63 (m, 2H, CH2), 1.34–1.28 (m, 10H, 5CH2), 0.89
(t, J = 6.83 Hz, 3H, CH3) ppm. HRMS (EI) calcd. for
C15H24N4O2: m/z = 292.18993, found: 292.18917. IR
(film): 2952, 1705, 1660, 1603, 1550, 1454, 1359, 1323,
1286, 1234, 1123, 763, 616 cm-1. Anal. calcd. for
C15H24N4O2: C 61.66, H 8.28, N 19.17; found: C 61.54, H
8.61, N 19.03.
1-Methyl-4-(methylamino)-1H-imidazole-5-N-(octyl)-car-
boxamide Brown oil. 1H NMR (500 MHz, CDCl3):
d = 7.49 (s, 1H, CH), 7.10 (s, 1H, N–H), 5.42–5.20 (N–H,
1H), 3.93–3.87 (m, 5H, N–CH2, CH3), 3.46 (s, 3H, CH3),
1.69–1.64 (m, 2H, CH2), 1.32–1.26 (m, 10H, 5CH2), 0.86
(t, J = 6.81 Hz, 3H) ppm. HRMS (EI) calcd. for
C14H26N4O: m/z = 266.38367, found: 266.38285. IR
(film): 3120, 3002, 2952, 2869, 1705, 1660, 1603, 1454,
1359, 1323, 1286, 1234, 1123, 1020, 973, 763, 616,
540 cm-1. Anal. calcd. for C14H26N4O: C 63.12, H 9.84, N
21.03; found: C 63.58, H 9.49, N 21.15.
3,7-Dihydro-2-octyloxy-3,7-dimethyl-6H-purine-6-one Col-
orless oil. 1H NMR (500 MHz, CDCl3): d = 7.50 (s, 1H,
CH), 4.02 (s, 3H, CH3), 3.86–3.81 (m, 2H, CH2O), 3.79 (s,
3H, CH3), 1.75–1.66 (m, 2H, CH2), 1.36–1.27 (m, 10H,
5CH2), 0.88 (t, J = 6.26 Hz, 3H, CH3) ppm. HRMS (EI)
calcd. for C15H24N4O2: m/z = 292.18993, found:
292.18897. IR (film): 3009, 2952, 2869, 1705, 1603, 1454,
1359, 1323, 1286, 1260, 1234, 1170, 1123, 763, 616 cm-1.
Anal. calcd. for C15H24N4O2: C 61.66, H 8.28, N 19.17;
found: C 61.78, H 8.32, N 19.37.
3,7-Dihydro-3,7-dimethyl-1-(hexadecyl)-1H-purine-2,6-dione
(3) White solid, mp 80–82 C, solvent for crystallization:
methanol. 1H NMR (500 MHz, CDCl3): d = 7.54 (s, 1H,
CH), 4.03–3.99 (m, 5H, N–CH2, CH3), 3.6 (s, 3H, CH3),
1.68–1.65 (m, 2H, CH2), 1.27–1.36 (m, 26H, 13CH2), 0.9
(t, J = 6.83 Hz, 3H, CH3) ppm. HRMS (EI) calcd. for
C23H40N4O2: m/z = 404.31513, found: 404.31479. IR
(film): 2955, 2918, 2850, 1713, 1660, 1555, 1469, 1214,
1122, 770, 617 cm-1. Anal. calcd. for C23H40N4O2: C
68.32, H 9.96, N 13.86; found: C 68.28, H 9.91, N 13.79.
1-Methyl-4-(methylamino)-1H-imidazole-5-N-(hexadecyl)-
carboxamide Brown oil. 1H NMR (500 MHz, CDCl3):
d = 7.25 (s, 1H, CH), 7.11 (s, 1H, N–H), 5.42–5.20 (N–H,
1H), 3.93–3.80 (m, 5H, N–CH2, CH3), 3.5 (s, 3H, CH3),
1.65–1.63 (m, 2H, CH2), 1.30–1.22 (m, 26H, 13CH2), 0.87
(t, J = 6.82 Hz, 3H) ppm. HRMS (EI) calcd. for C22H42N4O:
m/z = 378.59695, found: 378.59524. IR (film): 3135, 3000,
2955, 2918, 2870, 2850, 1713, 1660, 1469, 1214, 1122, 1027,
980, 770, 617, 530 cm-1. Anal. calcd. for C22H42N4O: C 69.79,
H 11.18, N 14.79; found: C 69.62, H 11.27, N 14.63.
3,7-Dihydro-2-hexadecyloxy-3,7-dimethyl-6H-purine-6-
one Colorless oil. 1H NMR (500 MHz, CDCl3):
d = 7.50 (s, 1H, CH), 4.02 (s, 3H, CH3), 3.86–3.81 (m, 2H,
CH2O), 3.78 (s, 3H, CH3), 1.76–1.67 (m, 2H, CH2),
1.32–1.25 (m, 26H, 13CH2), 0.89 (t, J = 7.25 Hz, 3H,
CH3) ppm. HRMS (EI) calcd. for C23H40N4O2: m/
z = 404.31513, found: 404.31438. IR (film): 3000, 2955,
2918, 2870, 2850, 1713, 1469, 1214, 1122, 1060, 770,
617 cm-1. Anal. calcd. for C23H40N4O2: C 68.32, H 9.96,
N 13.86; found: C 68.54, H 9.87, N 13.94.
3,7-Dihydro-3,7-dimethyl-1-(4-methyl-1-methylnaphthalene)-
1H-purine-2,6-dione (4) White solid, mp 206–208 C,
solvent for crystallization: ethyl acetate/petroleum ether
(1/1). 1H NMR (200 MHz, CDCl3): d = 8.31–8.26 (m, 1H,
HAr), 8.05–8.0 (m, 1H, HAr), 7.62–7.5 (m, 3H, CH, 2-HAr),
152 J Incl Phenom Macrocycl Chem (2012) 74:145–155
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7.24–7.14 (m, 2H, HAr), 5.69 (s, 2H, N–CH2), 3.99 (s, 3H,
CH3), 3.60 (s, 3H, CH3), 2.65 (s, 3H, CH3) ppm. HRMS
(EI) calcd. for C19H18N4O2: m/z = 334.14298, found:
334.14372. IR (film): 2957, 2931, 2859, 1705, 1659, 1605,
1549, 1484, 1454, 1358, 1326, 1286, 1234, 1122, 764, 750,
615 cm-1. Anal. calcd. for C19H18N4O2: C 68.29, H 5.43,
N 16.77; found: C 68.35, H 5.39, N 16.68.
1-Methyl-4-(methylamino)-1H-imidazole-5-N-(4-methyl-1-
methylnaphthalene)-carboxamide Colorless oil. 1H NMR
(500 MHz, CDCl3): d = 8.29–8.22 (m, 1H, HAr), 8.0–7.9
(m, 1H, HAr), 7.58–7.49 (m, 3H, CH, 2-HAr), 7.2 (s, 1H,
N–H), 7.19–7.1 (m, 2H, HAr), 6.9 (N–H, 1H), 5.63 (s, 2H,
N–CH2), 3.81 (s, 3H, CH3), 3.58 (s, 3H, CH3), 2.54 (s, 3H,
CH3) ppm. HRMS (EI) calcd. for C18H20N4O: m/z =
308.37915, found: 308.37821. IR (film): 3133, 3006, 2957,
2931, 2859, 1705, 1659, 1605, 1484, 1454, 1358, 1326,
1286, 1234, 1122, 1023, 973, 761, 756, 610 cm-1. Anal.
calcd. for C18H20N4O: C 70.11, H 6.54, N 18.17; found: C
70.38, H 6.48, N 18.09.
3,7-Dihydro-2-(4-methyl-1-methylnaphthalene)-3,7-dimethyl-
6H-purin-6-one Colorless oil. 1H NMR (500 MHz,
CDCl3): d = 8.24–8.21 (m, 1H, HAr), 7.93–7.91 (m, 1H,
HAr), 7.77–7.74 (m, 1H, HAr), 7.55 (s, 1H, CH), 7.47–7.45
(m, 1H, HAr), 7.22–7.09 (m, 2H, HAr), 5.53 (s, 2H, CH2O),
4.03 (s, 3H, CH3), 3.76 (s, 3H, CH3), 2.73 (s, 3H, CH3)
ppm. HRMS (EI) calcd. for C19H18N4O2: m/z =
334.14298, found: 334.14156. IR (film): 3006, 2957, 2931,
2875, 2859, 1705, 1605, 1484, 1454, 1358, 1326, 1286,
1234, 1122, 1060, 750, 615 cm-1. Anal. calcd. for
C19H18N4O2: C 68.29, H 5.43, N 16.77; found: C 68.41, H
5.38, N 16.59.
3,7-Dihydro-3,7-dimethyl-1-(benzyl)-1H-purine-2,6-dione
(5) White solid, mp 140–143 C, solvent for crystalliza-
tion: ethyl acetate/petroleum ether (1/1). 1H NMR
(500 MHz, CDCl3): d = 7.52–7.50 (m, 3H, CH, 2-HAr),
7.39–7.27 (m, 3H, HAr), 5.22 (s, 2H, CH2Ph), 4.00 (s, 3H,
CH3), 3.59 (s, 3H, CH3) ppm. HRMS (EI) calcd. for
C14H14N4O2: m/z = 270.11168, found: 270.11047. IR
(film): 2960, 2932, 2872, 1706, 1658, 1606, 1550, 1485,
1454, 1358, 1327, 1287, 1237, 1116, 943, 764, 616 cm-1.
Anal. calcd. for C14H14N4O2: C 62.25, H 5.22, N 20.74;
found: C 62.31, H 5.19, N 20.82.
1-Methyl-4-(methylamino)-1H-imidazole-5-N-(benzyl)-
carboxamide Colorless oil. 1H NMR (500 MHz, CDCl3):
d = 7.50–7.48 (m, 3H, CH, 2-HAr), 7.35–7.26 (m, 3H,
HAr), 7.1 (s, 1H, N–H), 5.6 (N–H, 1H), 5.19 (s, 2H,
CH2Ph), 3.88 (s, 3H, CH3), 3.57 (s, 3H, CH3) ppm. HRMS
(EI) calcd. for C13H16N4O: m/z = 244.29349, found:
244.29285. IR (film): 3129, 2960, 2932, 2872, 1706,
1658, 1606, 1485, 1454, 1358, 1327, 1287, 1237, 1020,
1116, 973, 943, 764, 616, 550 cm-1. Anal. calcd. for
C13H16N4O: C 63.91, H 6.60, N 22.93; found: C 63.84, H
6.72, N 22.79.
3,7-Dihydro-2-benzyloxy-3,7-dimethyl-6H-purine-6-one Col-
orless oil. 1H NMR (500 MHz, CDCl3): d = 7.56 (s, 1H,
CH), 7.50–7.27 (m, 5H, HAr), 4.88 (s, 2H, PhCH2O), 4.02
(s, 3H, CH3), 3.69 (s, 3H, CH3) ppm. HRMS (EI) calcd. for
C14H14N4O2: m/z = 270.11168, found: 270.11198. IR
(film): 3100, 2960, 2932, 2872, 2870, 1706, 1606, 1485,
1454, 1358, 1327, 1287, 1237, 1200, 1116, 1070, 943, 764,
616 cm-1. Anal. calcd. for C14H14N4O2: C 62.25, H 5.22,
N 20.74; found: C 62.47, H 5.47, N 20.97.
3,7-Dihydro-3,7-dimethyl-1-(butyl)-1H-purine-2,6-dione
(6) White solid, mp 109–112 C, solvent for crystalliza-
tion: ethyl acetate. 1H NMR (500 MHz, CDCl3): d = 7.52
(s, 1H, CH), 4.02 (t, J = 7.81 Hz, 2H, CH2), 4.0 (s, 3H,
CH3), 3.59 (s, 3H, CH3), 1.65 (q, J = 7.81 Hz, 2H, CH2),
1.45–1.39 (m, 2H, CH2), 0.97 (t, J = 7.32 Hz, 3H, CH3)
ppm. HRMS (EI) calcd. for C11H16N4O2: m/
z = 236.12733, found: 236.12626. IR (film): 2959, 1705,
1660, 1602, 1549, 1485, 1454, 1320, 1285, 1235, 1125,
752, 616 cm-1. Anal. calcd. for C11H16N4O2: C 55.95, H
6.83, N 23.72; found: C 55.89, H 6.85, N 23.67.
1-Methyl-4-(methylamino)-1H-imidazole-5-N-(butyl)-
carboxamide Colorless oil. 1H NMR (500 MHz, CDCl3):
d = 7.18 (s, 1H, CH), 5.75–5.6 (m, 2H, N–H), 3.83 (s, 3H,
CH3), 3.46 (s, 3H, CH3), 3.18–3.13 (m, 2H, N–CH2),
1.56–1.31 (m, 4H, CH2CH2), 0.82 (t, J = 7.1 Hz, 3H,
CH3) ppm. HRMS (EI) calcd. for C10H18N4O: m/z = 210.
27703, found: 210.27618. IR (film): 3130, 3000, 2959,
1705, 1660, 1602, 1485, 1454, 1320, 1285, 1235, 1125,
1025, 973, 752, 616, 550 cm-1. Anal. calcd. for
C10H18N4O: C 57.12, H 8.62, N 26.64; found: C 57.63, H
8.58, N 26.78.
3,7-Dihydro-2-butyloxy-3,7-dimethyl-6H-purine-6-one Col-
orless oil. 1H NMR (500 MHz, CDCl3): d = 7.52 (s, 1H,
CH), 3.91 (t, J = 7.76 Hz, 2H, CH2O), 4.0 (s, 3H, CH3),
3.79 (s, 3H, CH3), 2.65–2.51 (m, 2H, CH2), 1.78–1.72 (m,
2H, CH2), 0.84 (t, J = 6.57 Hz, 3H, CH3) ppm. HRMS
(EI) calcd. for C11H16N4O2: m/z = 236.12733, found:
236.12814. IR (film): 3002, 2959, 2870, 1704, 1601, 1483,
1454, 1320, 1284, 1235, 1123, 1060, 752 cm-1. Anal.
calcd. for C11H16N4O2: C 55.95, H 6.83, N 23.72; found: C
55.82, H 6.95, N 23.58.
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3,7-Dihydro-3,7-dimethyl-1-(pentyl)-1H-purine-2,6-dione
(7) Yellow solid, mp 98–100 C, solvent for crystalliza-
tion: diethyl ether. 1H NMR (500 MHz, CDCl3): d = 7.53
(s, 1H, CH), 4.02–3.99 (m, 5H, CH2CH3), 3.59 (s, 3H,
CH3), 1.38–1.35 (m, 6H, 3CH2), 0.92 (t, J = 6.84 Hz, 3H,
CH3) ppm. HRMS (EI) calcd. for C12H18N4O2: m/
z = 250.14298, found: 250.14410. IR (film): 2958, 1704,
1660, 1605, 1549, 1485, 1454, 1354, 1283, 1234, 1122,
703, 617 cm-1. Anal. calcd. for C12H18N4O2: C 57.62, H
7.25, N 22.39; found: C 57.59, H 7.19, N 22.36.
1-Methyl-4-(methylamino)-1H-imidazole-5-N-(pentyl)-
carboxamide Colorless oil. 1H NMR (500 MHz,
CDCl3): d = 7.48 (s, 1H, CH), 5.37–5.2 (m, 2H, N–H),
3.94–3.89 (m, 5H, CH2CH3), 3.55 (s, 3H, CH3), 1.35–1.32
(m, 6H, 3CH2), 0.9 (t, J = 6.83 Hz, 3H, CH3) ppm. HRMS
(EI) calcd. for C11H20N4O: m/z = 224.30369, found:
224.30284. IR (film): 3131, 3008, 2958, 1704, 1660, 1605,
1549, 1485, 1454, 1354, 1283, 1234, 1122, 1024, 971, 703,
617, 550 cm-1. Anal. calcd. for C11H20N4O: C 58.97, H
8.98, N 24.98; found: C 58.88, H 8.69, N 24.75.
3,7-Dihydro-2-pentyloxy-3,7-dimethyl-6H-purine-6-one Col-
orless oil. 1H NMR (500 MHz, CDCl3): d = 7.50 (s, 1H,
CH), 4.02 (s, 3H, CH3), 3.89–3.86 (m, 2H, CH2O), 3.79 (s,
3H, CH3), 1.81–1.75 (m, 2H, CH2), 1.49–1.37 (m, 4H,
2CH2), 0.93 (t, J = 6.96 Hz, 3H, CH3) ppm. HRMS (EI)
calcd. for C12H18N4O2: m/z = 250.14298, found:
250.14308. IR (film): 3018, 2958, 2876, 1704, 1605, 1485,
1454, 1354, 1283, 1234, 1122, 1065, 703, 617 cm-1. Anal.
calcd. for C12H18N4O2: C 57.62, H 7.25, N 22.39; found: C
57.78, H 7.43, N 22.28.
3,7-Dihydro-3,7-dimethyl-1-(dodecyl)-1H-purine-2,6-dione
(8) White solid, mp 69–71 C, solvent for crystallization:
petroleum ether/methanol (1/1). 1H NMR (500 MHz,
CDCl3): d = 7.53 (s, 1H, CH), 4.03–3.99 (m, 5H,
CH2CH3), 3.6 (s, 3H, CH3), 1.68–1.63 (m, 2H, CH2),
1.38–1.27 (m, 18H, 9CH2), 0.9 (t, J = 6.83 Hz, 3H, CH3)
ppm. HRMS (EI) calcd. for C19H32N4O2: m/z =
348.25253, found: 348.25124. IR (film): 2958, 1705, 1660,
1603, 1549, 1485, 1454, 1370, 1305, 1234, 1124, 750,
617 cm-1. Anal. calcd. for C19H32N4O2: C 65.52, H 9.26,
N 16.09; found: C 65.61, H 9.29, N 16.13.
1-Methyl-4-(methylamino)-1H-imidazole-5-N-(dodecyl)-
carboxamide Colorless oil. 1H NMR (500 MHz, CDCl3):
d = 7.48 (s, 1H, CH), 5.39–5.26 (m, 2H, N–H), 4.0–3.89
(m, 5H, CH2CH3), 3.55 (s, 3H, CH3), 1.61–1.67 (m, 2H,
CH2), 1.25–1.39 (m, 18H, 9CH2), 0.89 (t, J = 6.81 Hz, 3H,
CH3) ppm. HRMS (EI) calcd. for C18H34N4O: m/
z = 322.49031, found: 322.49149. IR (film): 3129, 3005,
2958, 1705, 1660, 1603, 1549, 1485, 1454, 1370, 1305,
1234, 1124, 1020, 970, 750, 617, 550 cm-1. Anal. calcd.
for C18H34N4O: C 67.04, H 10.63, N 17.37; found: C
67.11, H 10.56, N 17.28.
3,7-Dihydro-2-dodecyloxy-3,7-dimethyl-6H-purine-6-
one Colorless oil. 1H NMR (500 MHz, CDCl3): d =
7.50 (s, 1H, CH), 4.02 (s, 3H, CH3), 3.86–3.81 (m, 2H,
CH2O), 3.79 (s, 3H, CH3), 1.76–1.67 (m, 2H, CH2),
1.37–1.25 (m, 18H, 9CH2), 0.88 (t, J = 6.25 Hz, 3H, CH3)
ppm. HRMS (EI) calcd. for C19H32N4O2: m/
z = 348.25253, found: 348.25311. IR (film): 3015, 2958,
2874, 1705, 1603, 1485, 1454, 1370, 1305, 1234, 1124,
1070, 750, 617 cm-1. Anal. calcd. for C19H32N4O2: C
65.52, H 9.26, N 16.09; found: C 65.41, H 9.35, N 16.20.
3,7-Dihydro-3,7-dimethyl-1-(5-oxohexyl)-1H-purine-2,6-
dione (9) White solid, mp 102–105 C, solvent for crys-
tallization: ethyl acetate/petroleum ether (1/1). 1H NMR
(200 MHz, CDCl3): d = 7.51 (s, 1H, CH), 4.0–3.93 (m,
5H, CH2CH3), 3.56 (s, 3H, CH3), 2.49 (t, J = 6.96 Hz, 2H,
CH2), 2.13 (s, 3H, CH3), 1.65–1.63 (m, 4H, 2CH2) ppm.
HRMS (EI) calcd for C13H18N4O3: m/z = 278.13789,
found: 278.13680. IR (film): 2955, 2920, 2849, 1703, 1659,
1603, 1549, 1462, 1358, 1324, 1284, 1228, 1124, 941, 763,
617 cm-1. Anal. calcd. for C13H18N4O3: C 56.14, H 6.52,
N 20.14; found: C 56.19, H 6.48, N 20.09.
1-Methyl-4-(methylamino)-1H-imidazole-5-N-(5-oxohexyl)-
carboxamide Colorless oil. 1H NMR (200 MHz, CDCl3):
d = 7.21 (s, 1H, CH), 7.13 (s, 1H, N–H), 5.25–5.31 (N–H,
1H), 3.83 (s, 3H, CH3), 3.30 (q, J = 6.4 Hz, 2H, CH2),
2.85 (s, 3H, CH3), 2.48 (t, J = 6.8 Hz, 2H, CH2), 2.12 (s,
3H, CH3), 1.51–1.66 (m, 4H, 2CH2) ppm. HRMS (EI)
calcd. for C12H20N4O2: m/z = 252.3139, found:
252.31285. IR (film): 3130, 3000, 2955, 2920, 2849, 1703,
1659, 1603, 1549, 1462, 1358, 1324, 1284, 1228, 1124,
1010, 970, 941, 763, 617, 550 cm-1. Anal. calcd. for
C12H20N4O2: C 57.12, H 7.99, N 22.21; found: C 57.23, H
7.86, N 22.32.
3,7-Dihydro-2-(5-oxohexyloxy)-3,7-dimethyl-6H-purine-6-
one Colorless oil. 1H NMR (200 MHz, CDCl3): d = 7.56
(s, 1H, CH), 4.25 (m, 2H, CH2O), 4.08 (s, 3H, CH3), 3.79
(s, 3H, CH3), 2.49–2.43 (m, 2H, CH2), 2.17 (s, 3H, CH3),
1.68–1.62 (m, 4H, 2CH2) ppm. HRMS (EI) calcd. for
C13H18N4O3: m/z = 278.13789, found: 278.13826. IR
(film): 3008, 2955, 2920, 2870, 2849, 1703, 1659, 1603,
1462, 1358, 1324, 1284, 1228, 1170, 1124, 941, 763,
617 cm-1. Anal. calcd. for C13H18N4O3: C 56.14, H 6.52,
N 20.14; found: C 56.27, H 6.45, N 20.29.
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